For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the…
Q1-25 Revenue of € 144.1 Million and Net Income of € 31.5 MillionOrders of € 131.9 Million Up 8.2% vs.…
Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”), a biopharmaceutical company pioneering novel treatments for obesity,…
On Wednesday, 30 April, at 13:00 (EEST), Liven AS CEO Andero Laur and CFO Joonas Joost will host a Webinar,…
New funds provided largely by existing investors, led by Sandwater Phase 2 trial to be delivered through novel agreement between…
Image available: pr@jltmobile.com This announcement underscores JLT's long-term commitment to the port segment and their dedication to providing robust, reliable…
LEI: 2138002M5U5K4OUMVV62 Ringkjøbing Landbobank Aktieselskab (the “Issuer”) Notice of Issuer Call to the holders ofDKK 450,000,000 Callable Non-Preferred Senior Floating…
THIS ANNOUNCEMENT IS PUBLISHED PURSUANT TO SECTIONS 9(3)-(5) AND SECTION 21(3) OF EXECUTIVE ORDER NO. 636 OF 15 MAY 2020…
Press release23 April 2025 - N° 08 Philipp Rüede appointed CEO SCOR L&H and Member of SCOR’s Executive Committee We are…
First quarter Order intake for the first quarter increased by 97% to SEK 930 m (473). Organically, order intake increased…
This website uses cookies.